Diabetic retinopathy (DR) is the most common complication of diabetes mellitus (DM). It has
long been recognized as a microvascular disease. The diagnosis of DR relies on the …

Abstract Purpose of Review This review highlights indications and evidence on laser
therapy in the management of diabetic retinopathy and diabetic macular edema. Particular …

Diabetic retinopathy (DR) is a complication of diabetes and one of the leading causes of
vision loss worldwide. Despite extensive efforts to reduce visual impairment, the prevalence …

Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the
center of the macula, represents the most common cause of vision loss in patients affected …

Over the past two decades, selective laser trabeculoplasty (SLT) has increasingly become
an established laser treatment used to lower intraocular pressure in open-angle glaucoma …

In the past years, the management of diabetic retinopathy (DR) relied primarily on a good
systemic control of diabetes mellitus, and as soon as the severity of the vascular lesions …

Purpose.: Subthreshold retinal phototherapy demonstrated clinical efficacy for the treatment
of diabetic macular edema without visible signs of retinal damage. To assess the range of …

Medicinal lasers are a standard source of light to produce retinal tissue photocoagulation to
treat retinovascular disease. The Diabetic Retinopathy Study and the Early Treatment …

Purpose: Laser therapy for diabetic macular edema and other retinal diseases has been
used within a wide range of laser settings: from intense burns to nondamaging exposures …

The ocular drug discovery field has evidenced significant advancement in the past decade.
The FDA approvals of Rhopressa, Vyzulta, and Roclatan for glaucoma, Brolucizumab for wet …